Medications Being Studied for COVID-19

coronavirus-banner

Featured Updates

Remdesivir RCT Data CPE Video

FDA recently issued an EUA for remdesivir for the treatment of COVID-19. We take a closer look at the trial details and the resulting data.

Myth vs. Fact Webinar Video

We discuss some of the most common myths about the pathophysiology, transmission, treatment, and vaccines for COVID-19. 

Dexamethasone CPE Video

Finally there is a drug that has demonstrated improved survival outcomes in COVID-19. Fortunately for everyone, that drug is widely available, inexpensive, and familiar. 

Treatments Being Studied

Anticoagulation

APhA 15 on COVID-19: Anticoagulation (May 15)
Have you heard that patients with COVID-19 are at increased risk of clots? In today’s 15 on COVID-19 episode, we examine the available evidence, and also review the literature to determine if there is any benefit to anticoagulation in patients with COVID19. (CPE Video)

Convalescent Plasma

APhA 15 on COVID-19: Convalescent Plasma (April 13)
Recently, there have been an increasing number of news stories focusing on convalescent plasma as a potential therapy for COVID-19. Join us for today’s 15 on COVID-19 episode, where we explore the potential advantages, disadvantages, available evidence, and unanswered questions about convalescent plasma in COVID-19 disease. (CPE Video)

Dexamethasone

APhA 15 on COVID-19: Dexamethasone (July 31)
Finally there is a drug that has demonstrated improved survival outcomes in COVID-19. Fortunately for everyone, that drug is a widely available, inexpensive drug that we are all familiar with: dexamethasone. Join us for today's 15 on COVID-19 episode as we review the dexamethasone data in COVID-19. (CPE Video)

IL-6 Antagonists

APhA 15 on COVID-19: IL-6 Antagonists (April 6)
Tocilizumab is a drug used to treat a variety of autoimmune disorders; however, you may have been hearing a lot about its role in COVID-19 lately. Curious as to why an antirheumatic drug would be useful in COVID-19? Join us for today’s episode of 15 on COVID-19 as we find the connection. (CPE Video)

Hydroxychloroquine

APhA 15 on COVID-19: The Hydroxychloroquine Saga Continues (June 1)
Have you heard that hydroxychloroquine is associated with increased risk of mortality and cardiac arrhythmia? Join us for today's 15 on COVID-19 episode as we take a deeper look at the study that generated this information as well as some of the concerns that have been raised about the study. (CPE Video)

APhA 15 on COVID-19: Hydroxychloroquine Prophylaxis (May 22)
Has recent news spurred a surge of questions about the use of hydroxychloroquine for COVID-19 prophylaxis? Join is for today’s episode of 15 on COVID-19 as we explore this strange confluence of science and politics and focus on what the available data are actually telling us about the efficacy of hydroxychloroquine for COVID-19 prophylaxis. (CPE Video)

APhA 15 on COVID-19: Hydroxychloroquine Updates: Part II (April 20)
Join us for today’s 15 on COVID-19 episode as we finish our review of the new literature examining the clinical efficacy of hydroxychloroquine in COVID-19. Two new randomized, controlled trials offer new insights in the potential role of this much-hyped, often talked about antimalarial drug that has become one of the mainstays of COVID-19 therapy. (CPE Video)

APhA 15 on COVID-19: Hydroxychloroquine Updates (April 17)
Information about COVID-19 is exploding everywhere. Join us as we revisit hydroxychloroquine and examine the new literature that has been released since our inaugural episode in late March. There are several new studies that shed new light on the role of hydroxychloroquine in COVID-19. (CPE Video)

APhA 15 on COVID-19: Inaugural Episode (March 23)
Governments around the world, including the U.S. government, are considering the use of chloroquine or hydroxychloroquine for COVID-19. Join us for the inaugural episode of APhA’s 15 on COVID-19 series as we wade through the available data to find answers and separate fact from fiction. (CPE Video)

Remdesivir

APhA 15 on COVID-19: Remdesivir RCT Data (June 5)
The FDA issued an Emergency Use Authorization for remdesivir for the treatment of COVID-19 on May 1, 2020. Until recently, the data that resulted in the EUA were not available. Join us for today’s 15 on COVID-19 episode as we take a closer look at the trial details and the resulting data. (CPE Video)

APhA 15 on COVID-19: Remdesivir Updates (May 4)
Wherever you look, it seems that remdesivir is back in the news. Join us for today’s 15 on COVID-19 episode as we examine the results of two randomized, placebo-controlled trials looking at remdesivir for the treatment of COVID-19. (CPE Video)

APhA 15 on COVID-19: Viral Properties and Remdesivir Updates (April 24)
New information and new rumors about COVID-19 continue to come out every day. Join us for today’s episode as we dispel some recent rumors about remdesivir, as well as revisit some of the physical properties of the COVID-19 virus itself, such as aerosolization properties and surface stability. (CPE Video)

APhA 15 on COVID-19: Remdesivir (April 3)
Have you been hearing about remdesivir as a potential treatment for COVID-19? Are you looking to learn more about remsdesivir and how it works? Get answers to these questions and more in this episode of 15 on COVID-19, where we explore the role of remdesivir in the treatment of COVID-19. (CPE Video)

Vitamins and Minerals

APhA 15 on COVID-19: Vitamin C (May 1)
Many patients are looking for ways to protect themselves from COVID-19, and are looking to their pharmacist for advice. One of the most common questions that pharmacists are getting is about Vitamin C. Join us for today’s 15 on COVID-19 episode, as we examine the available data regarding the use of Vitamin-C in COVID-19. (CPE Video)

APhA 15 on COVID-19: Zinc (April 27)
One of the most frequent COVID-19 questions that pharmacists are receiving is about the use of zinc in COVID-19. Join us for today’s episode as we examine the literature and discover what it tells us about the role of zinc in COVID-19. (CPE Video)

Public Resource Links

NIH developed treatment guidelines to inform clinicians how to care for patients with COVID-19. (Real-Time)

A series of short videos from the Society of Infectious Diseases Pharmacists that provide an overview of treatment options for COVID-19 and pertinent drug information. (Videos)

A compilation from IDStewardship.com of insights, guidelines, and resources to inform pharmacists about treatment options for COVID-19 and other clinical considerations. (Real-Time)

Other Medications

APhA 15 on COVID-19: Sedation Drugs (May 8)
As many as 12% of patients who are hospitalized for COVID-19 require mechanical ventilation. As the COVID-19 pandemic hits different areas of the country, some hospitals are reporting shortages of key medications used to keep intubated patients sedated. Join us for this 15 on COVID-19 episode as we examine strategies to maximize the availability of key medications for intubated patients. (CPE Video)

APhA 15 on COVID-19: ACE-I and ARBs (March 30)
Are patients asking about whether or not they should continue ACE-inhibitor or ARB therapy in light of the COVID-19 pandemic? Get answers to this question and more in this episode of 15 on COVID-19, where we explore the connection between ACEinhibitors and ARBs to COVID-19. (CPE Video)

APhA 15 on COVID-19: NSAIDs (March 27)
Confused about whether or not it’s safe to use NSAIDs in COVID-19 disease? You’re not alone. Join us for today’s 15 on COVID-19 episode, where we will review the available data, as well as the series of events that has resulted in so much confusion about the role of NSAIDs in COVID-19 disease. (CPE Video)

 

General Information

APhA Weekly Open Forum Webinar: Myth vs. Fact (October 15)
We help pharmacists remain a source of truth in their communities by discussing some of the most common myths about the pathophysiology, transmission, treatment, and vaccines for COVID-19. (Video - Slides) 

APhA Weekly Open Forum Webinar: Medications Being Studied (June 25)
Watch featured speaker Dan Zlott, APhA Vice President, Professional Education Resources, discuss the latest information on medications being used/studied for COVID-19 prevention and treatment. Information on late-breaking updates also was available. (Video - Slides)

APhA Weekly Open Forum Webinar: Medications Being Studied; Testing in a Community Pharmacy (April 23)
Hear an update on the most recent evidence for medications being studied for COVID-19. And Tennessee pharmacist Beth Bryan, PharmD, shares her front-line perspective on launching COVID-19 testing in a community pharmacy. (Video - Slides)

APhA Know the Facts: FAQs on Medications Being Studied for Potential Use in the Treatment of COVID-19 (March 30)
Stay informed with the latest information regarding medications being studied for potential use in the treatment of COVID-19. (PDF)

APhA Know the Facts: Commercially Available Medications Being Studied for COVID-19 (March 30)
Learn FDA-approved indications, contraindications, precautions, and counseling points for medications linked to FDA labeling. (PDF)

Key Links